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background:  Hepatic fibrosis is highly prevalent among adults with single ventricles and Fontan physiology. Few data exist to guide screening for 
liver disease in this population. Biomarkers, such as FibroSURE and hyaluronic acid (HA), are validated tests for hepatic fibrosis in viral hepatitis, 
alcoholic liver disease and non-alcoholic fatty liver disease. We sought to explore whether these tests can identify individuals with Fontan circulation 
who have advanced hepatic fibrosis or cirrhosis.
methods:  Subjects from the Alliance for Adult Research in Congenital Cardiology (AARCC) Fontan Liver Health study were enrolled who had liver 
biopsy and FibroSURE or HA testing within 6 months of biopsy. All biopsies were reviewed independently by two pathologists, and correlations 
between these biomarkers and hepatic fibrosis or cirrhosis were sought.
results:  Twenty-seven subjects were enrolled from three adult congenital heart disease centers. Median age was 26.8y (range 17.4 to 59.8). 
Median time since Fontan surgery was 20.4y (12.0 to 31.3). All subjects had an atriopulmonary connection (56%) or lateral tunnel Fontan (44%). 
None had known hepatitis C infection. FibroSURE score (>0.21) was elevated in 91% of subjects and was suggestive of cirrhosis (>0.74) in 13%; a 
similar distribution was seen in previous studies of Fontan patients. HA suggested cirrhosis (>46 ng/mL) in 18% of subjects. On histopathology, 42% 
of subjects had severe portal fibrosis with cirrhotic nodules; sinusoidal fibrosis involving >2/3 of sinusoids was seen in 63%. FibroSURE score and 
HA did not correlate with degree of portal or sinusoidal fibrosis and did not predict cirrhosis. FibroSURE, but not HA, correlated strongly with MELD-XI 
score (rs=0.6, p=0.006); neither correlated with peak VO2.
conclusions:  Abnormal biomarkers for hepatic fibrosis, and hepatic fibrosis or cirrhosis on biopsy are common in adults with Fontan circulation. 
FibroSURE and HA do not accurately predict degree of histopathologic hepatic fibrosis in these patients. FibroSURE correlates with MELD-XI score, a 
known predictor for adverse outcomes in Fontan patients. Further studies are needed to guide surveillance of liver disease in this population.
